{"entity":{"type":"insider","cik":"0001283290","url":"/insider/0001283290","json_url":"/insider/0001283290.json","name":"Lim Jonathan E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":222,"n_filings":22,"first":"2004-08-18","last":"2023-12-06","span_basis":"filed_date"},"name_variants":[{"name":"Lim Jonathan E","source":"filing","n_filings":21,"first_seen":"2007-06-01","last_seen":"2023-12-06"},{"name":"LIM JONATHAN E","source":"filing","n_filings":1,"first_seen":"2004-08-18","last_seen":"2004-08-18"}],"transactions":[{"id":8000170,"accession":"0001209191-23-057681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057681","line_url":"/filing/0001209191-23-057681#line-2","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (Chairman & CEO), Ten percent owner","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":278150.0,"shares_display":"278,150","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":478418.0,"total_display":"478,418.00","shares_owned_after":12899360.0,"shares_owned_after_display":"12,899,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-06","scope":"insider"},{"id":8000165,"accession":"0001209191-23-057681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057681","line_url":"/filing/0001209191-23-057681#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (Chairman & CEO), Ten percent owner","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":721850.0,"shares_display":"721,850","price_per_share":1.687,"price_display":"1.69","price_state":"stated","total_value":1217760.95,"total_display":"1,217,760.95","shares_owned_after":12899360.0,"shares_owned_after_display":"12,899,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":7923580,"accession":"0001209191-23-052403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052403","line_url":"/filing/0001209191-23-052403#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (Chairman & CEO), Ten percent owner","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":2.026,"price_display":"2.03","price_state":"stated","total_value":2026000.0,"total_display":"2,026,000.00","shares_owned_after":19456216.0,"shares_owned_after_display":"19,456,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-10","scope":"insider"},{"id":7972410,"accession":"0001209191-23-035590","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035590","line_url":"/filing/0001209191-23-035590#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (Chairman & CEO), Ten percent owner","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":275000.0,"total_display":"275,000.00","shares_owned_after":18396216.0,"shares_owned_after_display":"18,396,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-08","scope":"insider"},{"id":8723300,"accession":"0001209191-23-021458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021458","line_url":"/filing/0001209191-23-021458#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (Chairman & CEO), Ten percent owner","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.84,"price_display":"2.84","price_state":"stated","total_value":284000.0,"total_display":"284,000.00","shares_owned_after":18296216.0,"shares_owned_after_display":"18,296,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-28","scope":"insider"},{"id":7948732,"accession":"0001209191-23-002802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002802","line_url":"/filing/0001209191-23-002802#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (Chairman & CEO), Ten percent owner","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":3.857,"price_display":"3.86","price_state":"stated","total_value":231420.0,"total_display":"231,420.00","shares_owned_after":20256222.0,"shares_owned_after_display":"20,256,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-10","scope":"insider"},{"id":6632660,"accession":"0001209191-22-061352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-061352","line_url":"/filing/0001209191-22-061352#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (Chairman & CEO), Ten percent owner","officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":199600.0,"total_display":"199,600.00","shares_owned_after":20196222.0,"shares_owned_after_display":"20,196,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":2993238,"accession":"0001209191-16-109694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-109694","line_url":"/filing/0001209191-16-109694#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO & Director), Ten percent owner","officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24852.0,"shares_display":"24,852","price_per_share":5.5078,"price_display":"5.51","price_state":"stated","total_value":136879.8456,"total_display":"136,879.85","shares_owned_after":3350000.0,"shares_owned_after_display":"3,350,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-17","filed_date":"2016-03-21","scope":"insider"},{"id":8254390,"accession":"0001209191-15-067373","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-067373","line_url":"/filing/0001209191-15-067373#line-4","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO & Director), Ten percent owner","officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":12.6899,"price_display":"12.69","price_state":"stated","total_value":21572.83,"total_display":"21,572.83","shares_owned_after":3325108.0,"shares_owned_after_display":"3,325,108","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-21","scope":"insider"},{"id":8254388,"accession":"0001209191-15-067373","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-067373","line_url":"/filing/0001209191-15-067373#line-3","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO & Director), Ten percent owner","officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40.0,"shares_display":"40","price_per_share":12.7672,"price_display":"12.77","price_state":"stated","total_value":510.688,"total_display":"510.69","shares_owned_after":3325148.0,"shares_owned_after_display":"3,325,148","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-21","scope":"insider"},{"id":8254386,"accession":"0001209191-15-067373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-067373","line_url":"/filing/0001209191-15-067373#line-2","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO & Director), Ten percent owner","officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":12.9518,"price_display":"12.95","price_state":"stated","total_value":84186.7,"total_display":"84,186.70","shares_owned_after":3323168.0,"shares_owned_after_display":"3,323,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-21","scope":"insider"},{"id":8254384,"accession":"0001209191-15-067373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-067373","line_url":"/filing/0001209191-15-067373#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO & Director), Ten percent owner","officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":240.0,"shares_display":"240","price_per_share":13.05,"price_display":"13.05","price_state":"stated","total_value":3132.0,"total_display":"3,132.00","shares_owned_after":3323408.0,"shares_owned_after_display":"3,323,408","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-21","scope":"insider"},{"id":8846733,"accession":"0001209191-15-028872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-028872","line_url":"/filing/0001209191-15-028872#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO & Director), Ten percent owner","officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":9.01,"price_display":"9.01","price_state":"stated","total_value":180200.0,"total_display":"180,200.00","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider"},{"id":6384446,"accession":"0001209191-14-053585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-053585","line_url":"/filing/0001209191-14-053585#line-1","is_derivative":false,"issuer_cik":"0001283290","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001283290","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO & Director), Ten percent owner","officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.5994,"price_display":"7.60","price_state":"stated","total_value":37997.0,"total_display":"37,997.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-15","filed_date":"2014-08-19","scope":"insider"},{"id":3779643,"accession":"0001418145-08-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001418145-08-000022","line_url":"/filing/0001418145-08-000022#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":6.06,"price_display":"6.06","price_state":"stated","total_value":1515000.0,"total_display":"1,515,000.00","shares_owned_after":680000.0,"shares_owned_after_display":"680,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-20","filed_date":"2008-03-24","scope":"insider"},{"id":7371501,"accession":"0001418145-07-000008","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-15","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5100.0,"shares_display":"5,100","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":42075.0,"total_display":"42,075.00","shares_owned_after":709400.0,"shares_owned_after_display":"709,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371499,"accession":"0001418145-07-000008","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-14","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3360.0,"shares_display":"3,360","price_per_share":8.21,"price_display":"8.21","price_state":"stated","total_value":27585.6,"total_display":"27,585.60","shares_owned_after":704440.0,"shares_owned_after_display":"704,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371497,"accession":"0001418145-07-000008","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-13","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2568.0,"shares_display":"2,568","price_per_share":8.31,"price_display":"8.31","price_state":"stated","total_value":21340.08,"total_display":"21,340.08","shares_owned_after":717432.0,"shares_owned_after_display":"717,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371495,"accession":"0001418145-07-000008","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-12","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2132.0,"shares_display":"2,132","price_per_share":8.3,"price_display":"8.30","price_state":"stated","total_value":17695.6,"total_display":"17,695.60","shares_owned_after":715300.0,"shares_owned_after_display":"715,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371493,"accession":"0001418145-07-000008","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-11","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":8.23,"price_display":"8.23","price_state":"stated","total_value":13168.0,"total_display":"13,168.00","shares_owned_after":707800.0,"shares_owned_after_display":"707,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371492,"accession":"0001418145-07-000008","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1440.0,"shares_display":"1,440","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":11808.0,"total_display":"11,808.00","shares_owned_after":703000.0,"shares_owned_after_display":"703,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371490,"accession":"0001418145-07-000008","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":8.18,"price_display":"8.18","price_state":"stated","total_value":9816.0,"total_display":"9,816.00","shares_owned_after":701502.0,"shares_owned_after_display":"701,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371488,"accession":"0001418145-07-000008","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-8","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":8.16,"price_display":"8.16","price_state":"stated","total_value":6528.0,"total_display":"6,528.00","shares_owned_after":700100.0,"shares_owned_after_display":"700,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371486,"accession":"0001418145-07-000008","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-7","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":602.0,"shares_display":"602","price_per_share":8.17,"price_display":"8.17","price_state":"stated","total_value":4918.34,"total_display":"4,918.34","shares_owned_after":700900.0,"shares_owned_after_display":"700,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371483,"accession":"0001418145-07-000008","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-6","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":8.27,"price_display":"8.27","price_state":"stated","total_value":3308.0,"total_display":"3,308.00","shares_owned_after":714800.0,"shares_owned_after_display":"714,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371480,"accession":"0001418145-07-000008","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-5","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":8.26,"price_display":"8.26","price_state":"stated","total_value":2478.0,"total_display":"2,478.00","shares_owned_after":714500.0,"shares_owned_after_display":"714,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371477,"accession":"0001418145-07-000008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-4","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":298.0,"shares_display":"298","price_per_share":8.19,"price_display":"8.19","price_state":"stated","total_value":2440.62,"total_display":"2,440.62","shares_owned_after":702702.0,"shares_owned_after_display":"702,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371475,"accession":"0001418145-07-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":8.29,"price_display":"8.29","price_state":"stated","total_value":829.0,"total_display":"829.00","shares_owned_after":715200.0,"shares_owned_after_display":"715,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7371473,"accession":"0001418145-07-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001418145-07-000008","line_url":"/filing/0001418145-07-000008#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":8.06,"price_display":"8.06","price_state":"stated","total_value":806.0,"total_display":"806.00","shares_owned_after":700000.0,"shares_owned_after_display":"700,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-30","filed_date":"2007-12-04","scope":"insider"},{"id":7621920,"accession":"0001380444-07-000064","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12700.0,"shares_display":"12,700","price_per_share":9.03,"price_display":"9.03","price_state":"stated","total_value":114681.0,"total_display":"114,681.00","shares_owned_after":707200.0,"shares_owned_after_display":"707,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7621919,"accession":"0001380444-07-000064","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4700.0,"shares_display":"4,700","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":42488.0,"total_display":"42,488.00","shares_owned_after":702500.0,"shares_owned_after_display":"702,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7621917,"accession":"0001380444-07-000064","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-8","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4700.0,"shares_display":"4,700","price_per_share":9.02,"price_display":"9.02","price_state":"stated","total_value":42394.0,"total_display":"42,394.00","shares_owned_after":719900.0,"shares_owned_after_display":"719,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7621915,"accession":"0001380444-07-000064","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-7","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1090.0,"shares_display":"1,090","price_per_share":9.06,"price_display":"9.06","price_state":"stated","total_value":9875.4,"total_display":"9,875.40","shares_owned_after":700700.0,"shares_owned_after_display":"700,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7621914,"accession":"0001380444-07-000064","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-6","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":710.0,"shares_display":"710","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":6425.5,"total_display":"6,425.50","shares_owned_after":701790.0,"shares_owned_after_display":"701,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7621913,"accession":"0001380444-07-000064","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-5","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":9.01,"price_display":"9.01","price_state":"stated","total_value":3604.0,"total_display":"3,604.00","shares_owned_after":724600.0,"shares_owned_after_display":"724,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7621911,"accession":"0001380444-07-000064","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-4","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":9.15,"price_display":"9.15","price_state":"stated","total_value":2745.0,"total_display":"2,745.00","shares_owned_after":700100.0,"shares_owned_after_display":"700,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7621910,"accession":"0001380444-07-000064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":9.07,"price_display":"9.07","price_state":"stated","total_value":2721.0,"total_display":"2,721.00","shares_owned_after":700400.0,"shares_owned_after_display":"700,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":7621908,"accession":"0001380444-07-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001380444-07-000064","line_url":"/filing/0001380444-07-000064#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":9.16,"price_display":"9.16","price_state":"stated","total_value":916.0,"total_display":"916.00","shares_owned_after":700000.0,"shares_owned_after_display":"700,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-31","filed_date":"2007-11-02","scope":"insider"},{"id":6844786,"accession":"0001380444-07-000050","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-30","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":8.71,"price_display":"8.71","price_state":"stated","total_value":30485.0,"total_display":"30,485.00","shares_owned_after":676210.0,"shares_owned_after_display":"676,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844783,"accession":"0001380444-07-000050","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-29","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3010.0,"shares_display":"3,010","price_per_share":8.8,"price_display":"8.80","price_state":"stated","total_value":26488.0,"total_display":"26,488.00","shares_owned_after":686110.0,"shares_owned_after_display":"686,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844779,"accession":"0001380444-07-000050","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-28","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1880.0,"shares_display":"1,880","price_per_share":8.83,"price_display":"8.83","price_state":"stated","total_value":16600.4,"total_display":"16,600.40","shares_owned_after":691830.0,"shares_owned_after_display":"691,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844777,"accession":"0001380444-07-000050","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-27","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1610.0,"shares_display":"1,610","price_per_share":8.81,"price_display":"8.81","price_state":"stated","total_value":14184.1,"total_display":"14,184.10","shares_owned_after":689120.0,"shares_owned_after_display":"689,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844774,"accession":"0001380444-07-000050","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-26","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":13125.0,"total_display":"13,125.00","shares_owned_after":681160.0,"shares_owned_after_display":"681,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844771,"accession":"0001380444-07-000050","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-25","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1350.0,"shares_display":"1,350","price_per_share":8.76,"price_display":"8.76","price_state":"stated","total_value":11826.0,"total_display":"11,826.00","shares_owned_after":682660.0,"shares_owned_after_display":"682,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844768,"accession":"0001380444-07-000050","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-24","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1299.0,"shares_display":"1,299","price_per_share":8.89,"price_display":"8.89","price_state":"stated","total_value":11548.11,"total_display":"11,548.11","shares_owned_after":695410.0,"shares_owned_after_display":"695,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844765,"accession":"0001380444-07-000050","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-23","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":8.82,"price_display":"8.82","price_state":"stated","total_value":9702.0,"total_display":"9,702.00","shares_owned_after":690730.0,"shares_owned_after_display":"690,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844762,"accession":"0001380444-07-000050","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-22","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":950.0,"shares_display":"950","price_per_share":8.72,"price_display":"8.72","price_state":"stated","total_value":8284.0,"total_display":"8,284.00","shares_owned_after":679710.0,"shares_owned_after_display":"679,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844759,"accession":"0001380444-07-000050","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-21","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":8.79,"price_display":"8.79","price_state":"stated","total_value":7911.0,"total_display":"7,911.00","shares_owned_after":685210.0,"shares_owned_after_display":"685,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844755,"accession":"0001380444-07-000050","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-20","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":8.92,"price_display":"8.92","price_state":"stated","total_value":6244.0,"total_display":"6,244.00","shares_owned_after":697510.0,"shares_owned_after_display":"697,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"},{"id":6844752,"accession":"0001380444-07-000050","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001380444-07-000050","line_url":"/filing/0001380444-07-000050#line-19","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001283290","owner_name":"Lim Jonathan E","owner_url":"/insider/0001283290","role":"Director, Officer (President, CEO)","officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":8.88,"price_display":"8.88","price_state":"stated","total_value":6216.0,"total_display":"6,216.00","shares_owned_after":694710.0,"shares_owned_after_display":"694,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-28","filed_date":"2007-10-02","scope":"insider"}],"next_cursor":"2007-09-28|6844752","ledger_fault":false,"count":{"value":222,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":207,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":222},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001761918","name":"Erasca, Inc.","url":"/issuer/0001761918","role":"Director, Officer (Chairman & CEO), Ten percent owner","n_filings":6,"first_seen":"2022-12-15","last_seen":"2023-12-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001557421","name":"Ignyta, Inc.","url":"/issuer/0001557421","role":"Director, Officer (President, CEO & Director), Ten percent owner","n_filings":4,"first_seen":"2014-08-19","last_seen":"2016-03-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS INC","url":"/issuer/0001159036","role":"Director, Officer (President, CEO)","n_filings":12,"first_seen":"2004-08-18","last_seen":"2008-03-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283290","retrieved_at":"2026-08-22T00:01:27+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}